PYGB and pancreatic neoplasm: Similarly, another study found that human pancreatic cancer cell lines with low levels of glycogen phosphorylase B (PYGB) are more sensitive to glucose deprivation conditions, suggesting that PYGB could be a therapeutic target in those cancers with limited glucose levels [118].